Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread
about
Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutininsDetection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus cultureShotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses.Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.Possible basis for the emergence of H1N1 viruses with pandemic potential from avian hosts.Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulenceRecent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity.Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.Investigating virus-glycan interactions using glycan microarrays.Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analysesSwine as a model for influenza A virus infection and immunity.Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicityA Miniaturized Glycan Microarray Assay for Assessing Avidity and Specificity of Influenza A Virus Hemagglutinins.The sweet spot: defining virus-sialic acid interactions.Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trialChemistry of natural glycan microarrays.Influenza virus-glycan interactions.Quantitative comparison of human parainfluenza virus hemagglutinin-neuraminidase receptor binding and receptor cleavageNew insights into influenza A specificity: an evolution of paradigms.Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding.The direct and indirect effects of glycans on immune function.Host Immune Response to Influenza A Virus Infection.H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.Glycan-binding preferences and genetic evolution of human seasonal influenza A(H3N2) viruses during 1999-2007 in Taiwan.
P2860
Q27697647-26CDD7F6-873F-4B99-B6A6-F3C517509345Q28659731-8285291C-9296-460F-9BB6-6F24EC45A55EQ30362721-04202873-0D07-4228-A83A-91DDDD8B65B6Q30370985-71679042-C5BF-4CAE-850A-AB1430C7F9C5Q30377646-9E3AB636-111E-480B-B20E-2371F820A80EQ30394678-D039E110-43AA-4A74-9891-B8BBACF1086EQ30396804-806731FA-FC66-48DE-92AE-D86B2754CF21Q33573489-FB15482A-B4D1-4EB5-A1F4-7090E7911317Q34112133-6DDD1E13-7139-47FD-A5AB-890015BF55B5Q34262280-E80049EE-70D5-4154-BA99-E978BFC2D1B9Q35635820-7FDF010C-599A-4178-871C-D7A4DF6E8BB1Q35911143-4DF11003-CA3C-4234-B792-B3AC18E45EA0Q36047960-CE5FEFAF-533D-4B10-912A-FB05C3AC3DB8Q36685206-422821AE-2F6E-41B9-8BFC-62ABAD52FA0EQ36723410-CC207999-928E-4DC0-A388-EA3F8E727058Q37224897-F9BF868D-7E78-4E87-892F-5EE0EA0D9843Q37336357-9ADA02D0-D21A-4499-A395-F57FCCD2DCF1Q37643313-7025D68D-059F-48DF-95BA-FD9225540C04Q38184301-0ADE99DE-3102-464F-A271-19A235DC169AQ38233918-A27EA984-43AF-44BA-BFEF-EAA8CFA2247FQ38315039-33EAD627-53DB-435E-BBDC-519F79CE3BDCQ38694377-91A93BB9-B532-45DD-9BBE-0CABA3982EC2Q38795680-567C131A-612D-4DB0-86F2-7840AD310A90Q38802959-7E11B1EE-31A3-4557-B601-7B849A2B377CQ39956714-3AB3DC72-65D4-419B-A3CC-1992FA221D5DQ46632825-D20E6C8F-7B28-43D8-B988-102F1A460B0DQ52647758-9225AD3E-02DB-4EB3-A445-10367E9C7907Q54237872-4FBD6EC7-F584-47A6-8A66-4A20E6B345DDQ55373443-2BC472D2-00FB-4D8A-B5FA-F39ECC94F9EC
P2860
Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@ast
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@en
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@nl
type
label
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@ast
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@en
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@nl
prefLabel
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@ast
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@en
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@nl
P2093
P2860
P1433
P1476
Human H3N2 Influenza Viruses I ...... equences for Disease or Spread
@en
P2093
David F Smith
Kirsten St George
Richard D Cummings
Robert B Couch
Sara B Griesemer
Shelly Gulati
P2860
P304
P356
10.1371/JOURNAL.PONE.0066325
P407
P577
2013-06-21T00:00:00Z